Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar-Apr;31(2):263-266.
doi: 10.21873/invivo.11055.

Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review

Karnesh Chandrakant Patel  1 , George Kalantzis  2 , Nabil El-Hindy  2 , Bernard Y Chang  2
Affiliations
Review

Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review

Karnesh Chandrakant Patel et al. In Vivo. 2017 Mar-Apr.

Abstract

Orbital lymphangioma is a lymphatic system lesion that commonly presents in childhood. Management of these lesions is complex. Sclerotherapy is a therapy used to treat and shrink lesions prior to or as an alternative to surgery. We present three cases of orbital lymphangioma that were treated with sclerotherapy. Case 1: A 6-month-old boy was presented in 2010 with right ptosis and proptosis. Magnetic resonance imaging (MRI) identified a lesion involving the right orbit and face. Case 2: A 3-year-old girl was presented in 2011 with intermittent right periorbital swelling and medial canthal bleeding. MRI identified a soft-tissue lesion in the right orbit, extending into the face. Case 3: A 3-year-old girl was presented in 2012 with vomiting, and painful right proptosis. MRI identified an intra-conal lesion in the right orbit with fluid filled levels. All three patients were treated with sclerotherapy (sodium tetradecylsulfate). Sclerotherapy is a promising treatment for orbital lymphangioma. Its use may prevent the need for, or minimise the amount of surgical management. Several sclerosants are now commonly used to treat these lesions.

Keywords: Paediatric; lymphangioma; orbital; sclerotherapy; sodium tetradecylsulfate (STS).

PubMed Disclaimer

Figures

Figure 1
Figure 1. Case 1: T2-Weighted magnetic resonance imaging showing a lesion involving the right upper lid, extending into the extra and intraconal spaces medially, almost to the orbital apex
Figure 2
Figure 2. Case 1: T2-Weighted magnetic resonance imaging showing the lesion extending downwards towards the hard palate
Figure 3
Figure 3. Case 2: T2-Weighted magnetic resonance imaging showing a lesion medial to the right orbit, extending into the right orbit
Figure 4
Figure 4. Case 3: Computed tomographic scan showing a right intraconal lesion, with right upper lid soft-tissue involvement
See this image and copyright information in PMC

References

    1. Harris GJ, Sakol PJ, Bonavolontà G, De Conciliis C. An analysis of thirty cases of orbital lymphangioma. Pathophysiologic considerations and management recommendations. Ophthalmology. 1990;97(12):1583–1592. - PubMed
    1. Jones IS. Lymphangiomas of the ocular adnexa: an analysis of 62 cases. Trans Am Ophthalmol Soc. 1959;57:602–665. - PMC - PubMed
    1. Iliff WJ, Green WR. Orbital lymphangiomas. Ophthalmology. 1979;86(5):914–929. - PubMed
    1. Malhotra AD, Parikh M, Garibaldi DC, Merbs SL, Miller NR, Murphy K. Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer. Am J Neuroradiol. 2005;26(10):2630–2634. - PMC - PubMed
    1. Tunç M, Sadri E, Char DH. Orbital lymphangioma: an analysis of 26 patients. Br J Ophthalmol. 1999;83(1):76–80. - PMC - PubMed

Substances

LinkOut - more resources